Skip to main content
logo
Biocon Limited (NSE:BIOCON)
India flag India · Delayed Price · Currency is INR
413.90
-2.90 (-0.70%)
Jun 3, 2026, 12:41 PM IST

Biocon Revenue

In the fiscal year ending March 31, 2026, Biocon had annual revenue of 169.27B INR with 10.91% growth. Biocon had revenue of 45.17B in the quarter ending March 31, 2026, with 2.25% growth.

Revenue
169.27B
Revenue Growth
+10.91%
P/S Ratio
3.98
Revenue / Employee
10.31M
Employees
16,420
Market Cap
674.54B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026169.27B16.65B10.91%
Mar 31, 2025152.62B5.06B3.43%
Mar 31, 2024147.56B35.82B32.05%
Mar 31, 2023111.74B29.90B36.54%
Mar 31, 202281.84B10.41B14.57%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Dishman Carbogen Amcis29.32B
Anthem Biosciences21.24B
OneSource Specialty Pharma14.37B
Concord Biotech10.55B
Blue Jet Healthcare9.47B
Supriya Lifescience8.28B
Panacea Biotec6.57B
Zota Health Care5.39B
Revenue Rankings

Biocon News

More News